INS and type 1 diabetes mellitus: Recently, a new regimen has come into being, consisting of multi-dose injection (MDI) or, as mentioned earlier, continuous subcutaneous insulin infusion (CSII), with routine monitoring of blood sugar, has resulted in reasonable metabolic control in T1DM patients, but the effect of this therapy on height is still unclear [46].